Dr. Agarwal's Health Care financials

·Pharma & HealthChart ›
Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹614cr+26.0% on Q1 FY26
Net profit
₹55.0cr+44.6% on Q1 FY26
EBITDA margin
27.8%+1.5 pts on Q1 FY26
EPS
₹1.43+50.5% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue614487+26.0%
EBITDA170128+33.3%
EBITDA margin27.8%26.2%+1.5 pts
Profit before tax75.153.6+40.2%
Net profit55.038.1+44.6%
EPS₹1.43₹0.95+50.5%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹614 crNet profit₹55.0 crNet margin9.0%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025
15,053——
243243367
94.294.260.2
157157247
15,061——
2,2072,0801,711
—+21.6%—
612570456
27.7%27.4%26.7%
321293226
185168110
8.4%8.1%6.5%
₹4.68₹4.20₹2.63
—+59.6%—
—519360
—−461−321
58.458.439.4
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

AGARWALEYE₹475.15

Dr. Agarwal's Health Care Ltd.

· Pharma & Health
₹ CrorePeersAKUMSADVENZYMESALIVUSAARTIPHARMAARTIDRUGSAPLLTDCORONAHCGMcap ₹15,053 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization——15,052.8
- Cash, Equiv & ST Investments367.3242.9242.9
+ Minority Interest60.294.294.2
+ Total Debt246.9157.3157.3
Enterprise Value——15,061.4
Revenue1,711.02,080.12,206.7
Growth %, YoY—+21.6—
EBITDA456.4569.6612.1
Margin %26.6727.3827.74
EBIT225.6293.3320.5
Net Income110.3168.1185.1
Margin %6.458.088.39
EPS, Adj (current shares)2.634.204.68
Growth %, YoY—+59.6—
Cash from Operations360.3519.0—
Capital Expenditures-320.9-460.6—
Free Cash Flow39.458.458.4
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Dr. Agarwal's Health Care financials and key ratios

Prices at the 29 October 2026 close · figures from the company's filings with NSE

Dr. Agarwal's Health Care (NSE: AGARWALEYE) had a market capitalisation of ₹15,492 crore at the 29 October 2026 close (₹488.70 a share), a PE ratio of 104.4 on the last four quarters' profit and a price-to-book ratio of 7.65. In FY26 its consolidated net profit attributable to shareholders was ₹133 crore on revenue of ₹2,080 crore; in Q1 FY27 (April–June 2026) it was ₹45.2 crore, up 50.5% year on year. Its debt-to-equity ratio was 0.07 on 31 March 2026. Promoters held 32.33% of the shares on 30 September 2026.

Share price used
₹488.70 · 29 October 2026 close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026
Share price and live chart
₹488.70 · 29 Oct close

Dr. Agarwal's Health Care at a glance · consolidated

Market cap
₹15,492 Crat ₹488.70 · 29 Oct close
PE ratio (last 4 quarters)
104.4116.3 on FY26 profit
Price to book (PB)
7.65book value ₹63.89 a share
ROE (FY26)
6.8%ROCE 8.8%
Debt to equity
0.07net cash ₹124 Cr
Promoter holding
32.33%unchanged vs 30 Jun 202630 September 2026
Net worth
₹2,025 Cr+8.5% vs 31 Mar 202531 March 2026
Free cash flow (FY26)
₹58.4 Cr+48.1% vs FY25
EPS (FY26)
₹4.21

Questions

What is the Dr. Agarwal's Health Care PE ratio today?

Dr. Agarwal's Health Care's PE ratio is 104.4 at the 29 October 2026 close (₹488.70 a share): a market capitalisation of ₹15,492 crore divided by consolidated net profit attributable to shareholders of ₹148 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit attributable to shareholders (₹133 crore) it is 116.3.

What is the Dr. Agarwal's Health Care PB ratio (price to book value)?

Dr. Agarwal's Health Care's price-to-book (PB) ratio is 7.65 at the 29 October 2026 close: a market capitalisation of ₹15,492 crore divided by shareholders' equity (book value) of ₹2,025 crore on 31 March 2026. That is a book value of ₹63.89 per share against a share price of ₹488.70.

What is the Dr. Agarwal's Health Care ROE and ROCE?

In FY26, Dr. Agarwal's Health Care's return on equity (ROE) was 6.8% and its return on capital employed (ROCE) was 8.8%. ROE is net profit attributable to shareholders divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities).

What is the Dr. Agarwal's Health Care market cap?

Dr. Agarwal's Health Care's market capitalisation was ₹15,492 crore at the 29 October 2026 close: 31.7 crore shares at ₹488.70 each.

Is Dr. Agarwal's Health Care debt free?

No. Dr. Agarwal's Health Care had borrowings of ₹157 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.07. Its cash and current investments were ₹282 crore, so it held net cash of ₹124 crore.

What is the Dr. Agarwal's Health Care EPS?

Dr. Agarwal's Health Care's basic earnings per share (EPS) were ₹4.21 in FY26, against ₹2.80 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹4.69.

What is the Dr. Agarwal's Health Care debt to equity ratio?

Dr. Agarwal's Health Care's debt-to-equity ratio was 0.07 on 31 March 2026: borrowings of ₹157 crore against total equity of ₹2,120 crore. A year earlier, on 31 March 2025, it was 0.13.

What is the Dr. Agarwal's Health Care revenue and profit in FY26?

In FY26 (April 2025–March 2026), Dr. Agarwal's Health Care's consolidated net profit attributable to shareholders was ₹133 crore, up 59.6% from ₹83.5 crore in FY25, on revenue from operations of ₹2,080 crore (up 21.6%).

When are the Dr. Agarwal's Health Care next results?

Dr. Agarwal's Health Care will announce its Q2 FY27 results (July–September 2026) on Thursday, 5 November 2026, the date of the board meeting it has notified to the exchanges.

What is the Dr. Agarwal's Health Care net worth?

Dr. Agarwal's Health Care's net worth — shareholders' equity in its consolidated balance sheet — was ₹2,025 crore on 31 March 2026, up 8.5% from ₹1,867 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹15,492 crore at the 29 October 2026 close.

What is the Dr. Agarwal's Health Care book value per share?

Dr. Agarwal's Health Care's book value per share was ₹63.89 on 31 March 2026: shareholders' equity of ₹2,025 crore divided by the 31.7 crore shares in issue, up 8.1% from ₹59.09 a year earlier. The share price at the 29 October 2026 close was ₹488.70.

What is the Dr. Agarwal's Health Care promoter holding?

Promoters held 32.33% of Dr. Agarwal's Health Care on 30 September 2026, down 0.01 percentage points from 32.34% the previous quarter and down 0.09 percentage points from 32.42% a year earlier, according to the shareholding pattern filed with NSE.

What is the Dr. Agarwal's Health Care shareholding pattern?

On 30 September 2026, Dr. Agarwal's Health Care's shares were held by promoters 32.33%, foreign portfolio investors (FII/FPI) 49.56%, domestic institutions (DII) 15.87% (including mutual funds at 14.18%) and retail and other non-institutional investors 2.24%. Over the year, FII holding was down 8.57 percentage points from 58.13% and DII holding was up 7.95 percentage points from 7.92%.

How does Dr. Agarwal's Health Care compare with its peers?

On FY26 consolidated figures, against Akums Drugs and Pharmaceuticals and Advanced Enzyme Tech: Dr. Agarwal's Health Care's operating margin of 14.1% is the second highest of the three (Akums Drugs and Pharmaceuticals 8.4%, Advanced Enzyme Tech 25.3%; peer average 16.9%); its return on equity of 6.8% is the lowest of the three (Akums Drugs and Pharmaceuticals 8.0%, Advanced Enzyme Tech 11.1%; peer average 9.5%).

How does the Dr. Agarwal's Health Care PE ratio compare with its peers?

At the 29 October 2026 closing prices, on FY26 net profit attributable to shareholders, Dr. Agarwal's Health Care's PE ratio is 116.3, the highest of the three: Akums Drugs and Pharmaceuticals 44.5 and Advanced Enzyme Tech 17.5, a peer average of 31.0. Each is the company's market capitalisation at that price divided by its FY26 net profit.

What is the Dr. Agarwal's Health Care free cash flow?

In FY26, Dr. Agarwal's Health Care generated ₹519 crore of cash from operations and spent ₹461 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹58.4 crore. In FY25 it was ₹39.4 crore.

What are the Dr. Agarwal's Health Care latest quarterly results?

Dr. Agarwal's Health Care's latest results are for Q1 FY27 (April–June 2026), filed on 4 August 2026: consolidated net profit attributable to shareholders ₹45.2 crore, up 50.5% from ₹30.1 crore in Q1 FY26; revenue from operations ₹614 crore, up 26.0% year on year.

Dr. Agarwal's Health Care vs Akums Drugs and Pharmaceuticals: how do they compare?

In FY26, Dr. Agarwal's Health Care earned net profit attributable to shareholders of ₹133 crore on revenue of ₹2,080 crore, against ₹255 crore on ₹4,359 crore for Akums Drugs and Pharmaceuticals. Dr. Agarwal's Health Care's operating margin was 14.1% (Akums Drugs and Pharmaceuticals 8.4%) and its return on equity 6.8% (Akums Drugs and Pharmaceuticals 8.0%). At the 29 October 2026 close, Dr. Agarwal's Health Care's market capitalisation was ₹15,492 crore against ₹11,346 crore for Akums Drugs and Pharmaceuticals, and its PE ratio on FY26 profit 116.3 against 44.5.

Where do these Dr. Agarwal's Health Care figures come from?

From Dr. Agarwal's Health Care's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.